arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Envoy Medical, Inc.

COCH

$7.10 ▼ -0.09 (-1.25%) at close

23 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Envoy Medical, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $738.7M

Dividend Yield —

Revenue Growth -34.6% ↘

Op. Margin —

ROIC -133.2% ↘

FCF / Share $-0.05 ↗

Trailing P/E —

Price / Book 223.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$51.00K

↓ -34.6% —

Net Income Profit after all expenses

$-4.35M

↑ +12.9% —

FCF / Share Free cash flow per share

$-0.05

↑ +74.9% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↑

100

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Revenue Growth YoY (%)	-34.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-533%)	-15.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-290%)	78.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+882%)	-25.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-412%)	14.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+84%)	-22.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-375%)	-55.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-797%)	-30.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-475%)	7.9% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	—	375.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4588%)	40.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+404%)	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	78.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	72.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	10.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-10.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	9.4% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-400.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	77.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	92.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	12.9% Fair ↑ Fair Improving Year-over-year change in net income	12.9% Fair ↑ Fair Improving Year-over-year change in net income	-42.6% Weak ↓ Weak Declining Year-over-year change in net income	20.3% Good ↑ Good Improving Year-over-year change in net income	20.3% Good ↓ Good Declining Year-over-year change in net income	20.3% Good ↓ Good Declining Year-over-year change in net income	5.7% Fair ↓ Fair Declining Year-over-year change in net income	52.7% Excellent → Excellent Stable Year-over-year change in net income	52.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	57.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-608.3% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-94.2% Weak ↓ Weak Declining Year-over-year change in net income	-143.2% Weak Weak Year-over-year change in net income	-27.2% Weak Weak Year-over-year change in net income	N/M	N/M	—	—	—	—	—
FCF Growth YoY (%)	74.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	49.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	2.4% Caution ↓ Caution Declining Year-over-year change in free cash flow	16.5% Good Good Year-over-year change in free cash flow	41.3% Excellent Excellent Year-over-year change in free cash flow	—	—	37.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-6.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	55.4% Excellent Excellent Compound annual revenue growth over 3 years	-9.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	54.0% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	3.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
FCF / Net Income (x)	1.25x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.39x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.22x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.28x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.31x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-3.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.81x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	-0.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Return on Invested Capital (%)	-133.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	41.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	58.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	13.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	16.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	19.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	30.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	52.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	299.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.9% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	6.0% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	6.3% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	5.6% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	4.1% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	4.9% Caution → Caution Stable Return earned on debt + equity capital invested Optimal: > 10%	2.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	9.1% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	2.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-15.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-23.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-69.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-49.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-39.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-57.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-81.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-5.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-113.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-131.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-978%)	-42.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)	54.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+261%)	65.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+335%)	16.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	20.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+38%)	24.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+63%)	33.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+125%)	50.6% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+237%)	84.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+464%)	275.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1737%)	-211.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1512%)	29.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+96%)	-3.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	31.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+111%)	7.3% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	-58.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-487%)	-51.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-443%)	12.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	4.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-70%)	3.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	-29.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Interest Coverage (x)	-928.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-541.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-12.12x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	-48.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	$-7.44M	—	$-104.02K	$-183.00K	—	$-476.95K	$-127.11K	$-149.84K	—	—	$-2.15M	$-25.00K

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.01	$0.01	—	—	$0.01	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.07	$-0.08	$-0.26	$-0.35	$-0.32	$-0.29	$-0.40	$-0.39	$-0.29	$-0.32	$-0.08	$0.13	$-1.31	—	$-1.13	$-0.13	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.05	$-0.09	—	$-0.20	$-0.21	$-0.17	—	$-0.20	$-0.25	$-0.30	—	—	$-0.40	—	—	$-0.52	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.03	$0.15	—	$-0.35	$-1.40	$-1.14	—	$-0.99	$-0.67	$-0.38	—	$0.32	$-4.45	—	—	$-2.52	—	—	—	—	—	$0.41	—
Tangible Book Value per Share (USD)	$0.03	$0.15	—	$-0.35	$-1.40	$-1.14	—	$-0.99	$-0.67	$-0.38	—	$0.32	$-4.45	—	—	$-2.52	—	—	—	—	—	$0.41	—
Basic Weighted Avg Shares (shares)	104.04M	68.93M	—	21.85M	21.38M	21.33M	—	18.62M	18.60M	19.60M	—	10.21M	10.12M	—	—	10.12M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Working Capital (USD)	$9.28M	$15.47M	$-5.28M	$-3.23M	—	$717.00K	$1.36M	—	—	$734.00K	$171.00K	$9.13M	—	$-8.98M	$-871.00K	—	$-4.31M	$-3.30M	$-1.82M	—	—	$3.21M	$-70.69K
Total Equity (USD)	$3.30M	$10.16M	$-12.16M	$-7.66M	$-29.86M	$-24.22M	$-18.84M	$-18.54M	$-12.40M	$-7.41M	$-1.78M	$6.26M	$-45.03M	$-19.22M	$-36.20M	$-25.55M	$-21.45M	$-24.25M	$-36.71M	$-32.76M	$-38.33M	$5.00M	$24.30K

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Sales/Revenue/Turnover (USD)	$51.00K	$39.00K	$75.00K	$42.00K	$78.00K	$46.00K	$42.00K	$56.00K	$68.00K	$59.00K	$95.00K	$80.00K	$63.00K	—	$20.00K	$57.00K	—	—	—	—	—	—	—
Depreciation Expense (USD)	$74.00K	$73.00K	$80.00K	$76.00K	$85.00K	$61.00K	$48.00K	$49.00K	$42.00K	$34.00K	$48.00K	—	$29.00K	—	$26.00K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-4.35M	$-4.35M	$-6.59M	$-5.00M	$-5.00M	$-5.00M	$-4.62M	$-6.27M	$-6.27M	$-6.27M	$-4.89M	$-13.25M	$-13.25M	$717.70K	$-11.48M	$-1.87M	$12.46M	$12.46M	$-4.72M	$-1.47M	$-1.47M	$-1.47M	—
Operating Cash Flow (USD)	$-5.46M	$-6.06M	$-5.68M	$-4.33M	$-4.46M	$-3.73M	$-5.09M	$-2.62M	$-4.65M	$-5.85M	$-11.14M	—	$-4.03M	$-2.18M	$-2.38M	$-5.25M	—	$-772.74K	$-885.17K	$-701.35K	$-405.32K	$-1.25M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 6 years · 23 quarters

Envoy Medical, Inc.

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare COCH with peers